Edesa Biotech, Inc. held its annual general and special meeting of shareholders and approved an amendment to the 2019 Equity Incentive Compensation Plan, increasing the number of shares available for issuance by 67,000 shares.
AI Assistant
EDESA BIOTECH INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.